OraSure Technologies Net Change in Long-Term Investments 2010-2025 | OSUR
OraSure Technologies net change in long-term investments from 2010 to 2025. Net change in long-term investments can be defined as the net cash flows from the sale and purchase of investments with maturities greater than one year.
| OraSure Technologies Annual Net Change in Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $-30 |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $68 |
| 2020 | $18 |
| 2019 | $1 |
| 2018 | $-11 |
| 2017 | $-92 |
| 2016 | $N/A |
| 2015 | $-3 |
| 2014 | $N/A |
| 2013 | $N/A |
| 2012 | $N/A |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.230B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.711B | 27.62 |
| Boston Scientific (BSX) | United States | $154.351B | 38.64 |
| Stryker (SYK) | United States | $149.416B | 31.24 |
| EssilorLuxottica (ESLOY) | France | $132.057B | 0.00 |
| Medtronic (MDT) | Ireland | $115.083B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.474B | 25.39 |
| ResMed (RMD) | United States | $37.259B | 27.99 |
| Agilent Technologies (A) | United States | $34.110B | 22.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.090B | 16.18 |
| Terumo (TRUMY) | Japan | $24.459B | 31.77 |
| Koninklijke Philips (PHG) | Netherlands | $23.149B | 16.24 |
| Insulet (PODD) | United States | $20.550B | 80.67 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.570B | 11.93 |
| Baxter (BAX) | United States | $14.641B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.157B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.825B | 23.75 |
| Lantheus Holdings (LNTH) | United States | $5.747B | 14.50 |
| Prestige Consumer Healthcare (PBH) | United States | $3.776B | 16.87 |
| Perrigo (PRGO) | Ireland | $3.768B | 9.55 |
| Haemonetics (HAE) | United States | $3.683B | 16.77 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.395B | 28.21 |
| ICU Medical (ICUI) | United States | $3.220B | 23.75 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.42 |
| LeMaitre Vascular (LMAT) | United States | $1.900B | 42.47 |
| AtriCure (ATRC) | United States | $1.550B | 0.00 |
| Acuren (TIC) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 30.91 |
| Phibro Animal Health (PAHC) | United States | $1.278B | 16.34 |
| AdaptHealth (AHCO) | United States | $1.237B | 12.56 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.053B | 0.00 |
| InMode (INMD) | Israel | $0.932B | 9.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.792B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.749B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.661B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Evolus (EOLS) | United States | $0.613B | 0.00 |
| CeriBell (CBLL) | United States | $0.592B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.449B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.337B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.327B | 12.02 |
| Sanuwave Health (SNWV) | United States | $0.310B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.306B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.302B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 22.40 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 76.33 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.249B | 11.30 |
| Brainsway (BWAY) | Israel | $0.231B | 61.17 |
| Omeros (OMER) | United States | $0.230B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.221B | 6.22 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 15.00 |
| Vireo Growth (VREOF) | United States | $0.162B | 0.00 |
| Exagen (XGN) | United States | $0.151B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.13 |
| TerrAscend (TSNDF) | Canada | $0.115B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 13.05 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.094B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.00 |
| Safety Shot (SHOT) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.87 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |